Dr JoAnn Manson offers clinicians a new resource to guide discussions with patients about vitamins and supplements.

Drs Perales and Pasquini discuss the rapidly advancing field of CAR T and how patient safety and choice can be managed during these unprecedented times.

New research suggests that gamma-secretase modulators show promise in one-day treating Alzheimer dementia.

Set up to improve access to anti-cancer orphan drugs, the CDF did not live up to its promise, says Dr Kerr.

Drs Ann LaCasce and Caron Jacobson on how these and other treatments may change your practice in the new year.

New research explores the risk/benefit profile of reproductive hormone therapy in menopausal women with migraine.

Should we be concerned about, or take any action on, a new link found between this common antihypertensive agent and skin cancer?

Dr Alan Jacobs reports on a recent study suggesting that antihypertensive therapy might not return microcirculation to normal.

Hormone therapy must be discussed and individualized for each patient in order to achieve the best outcome for treating menopause.

Dr Andy Shorr comments on two trials of mepolizumab for patients with the eosinophilic phenotype of COPD.